SOURCE Endo Health Solutions Inc.
These stocks will be great stories in the second half of 2017, and are significantly undervalued.
Finding bullish and bearish reversals in the market.
The addition of Perrigo to the list of generics makers under investigation is more bad news for a sector already under pressure from low prices.
The investigation is in relation to drug pricing in the pharmaceutical industry.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.